(Q35294575)

English

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

scientific article published on 11 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

computed tomography

1 reference

based on heuristic

inferred from title

17

object named as

Hedvig Hricak

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

18

object named as

Dennis S Chi

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

15

object named as

Yukio Sonoda

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Nadeem R. Abu-Rustum

14

object named as

Nadeem R Abu-Rustum

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Ginger J. Gardner

13

object named as

Ginger J Gardner

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

8

object named as

Alexia Iasonos

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Douglas A Levine

16

object named as

Douglas A Levine

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Debra M Sarasohn

3

object named as

Debra M Sarasohn

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Carol Aghajanian

11

object named as

Carol A Aghajanian

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Svetlana Mironov

5

object named as

Svetlana Mironov

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1

object named as

Rudy S Suidan

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Jerrold B Teitcher

4

object named as

Jerrold B Teitcher

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

6

object named as

Revathy B Iyer

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Pedro T. Ramirez

2

object named as

Pedro T Ramirez

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Qin Zhou

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Harold Paul

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Masayoshi Hosaka

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Mario M Leitao

12

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

11 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

134

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

455-461

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Identification of prognostic factors in advanced epithelial ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

27 July 2018

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

26 September 2018

Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

26 September 2018

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

26 September 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

26 September 2018

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

26 September 2018

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

26 September 2018

A Laparoscopy-Based Score To Predict Surgical Outcome in Patients With Advanced Ovarian Carcinoma: A Pilot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4387777

15 November 2018

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

Ovarian carcinoma: value of CT in predicting success of debulking surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.07.002

7 January 2021

Identifiers

10.1016/J.YGYNO.2014.07.002

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

release_lwwcfr2l3ncljiofuliebgd74u

1 reference

https://api.fatcat.wiki/v0/release/lwwcfr2l3ncljiofuliebgd74u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35294575&oldid=2033079421"